BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: van der Vlugt M, Carvalho B, Fliers J, Montazeri N, Rausch C, Grobbee EJ, Engeland MV, Spaander MCW, Meijer GA, Dekker E. Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas. World J Gastrointest Oncol 2022; 14(11): 2195-2207 [PMID: 36438700 DOI: 10.4251/wjgo.v14.i11.2195]
URL: https://www.wjgnet.com/1948-5204/full/v14/i11/2195.htm
Number Citing Articles
1
Kai Sheng Saw, Kerry Sexton, Paul Frankish, Mike Hulme-Moir, Ian Bissett, Susan Parry. Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening PilotBMJ Open Gastroenterology 2023; 10(1): e001233 doi: 10.1136/bmjgast-2023-001233
2
Masau Sekiguchi, Yoshihiro Kishida, Hiroaki Ikematsu, Maki Konno, Yasuhiko Mizuguchi, Kinichi Hotta, Kenichiro Imai, Sayo Ito, Kazunori Takada, Akio Shiomi, Hirofumi Yasui, Shunsuke Tsukamoto, Hidekazu Hirano, Nozomu Kobayashi, Yutaka Saito, Atsushi Inaba, Kensuke Shinmura, Jun Konishi, Heita Ozawa, Shin Fujita, Yoshitaka Murakami, Takahisa Matsuda. Proportions and characteristics of interval cancer in annual fecal immunochemical test screening and postcolonoscopy colorectal cancer: Results from a Japanese multicenter prospective study using questionnaires, the C‐DETECT studyDigestive Endoscopy 2024;  doi: 10.1111/den.14772